52°
Feels Like: 52°
73°
55°
80°
By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers s...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Music, art and dance therapy may relieve anxiety and similar symptoms among people wi...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Children with even slightly elevated blood lead levels are less likely to be ready to rea...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Ovarian cancer rates in the U.S. began to decline faster in 2002 around the time many o...
Read More »FRANKFURT (Reuters) - German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate can...
Read More »
WASHINGTON (Reuters) - The Obama administration on Wednesday announced a $1 billion initiative to fund innovations in federal health...
Read More »FRANKFURT (Reuters) - German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug rego...
Read More »PARIS (Reuters) - French drugmaker Sanofi SA said it and U.S. firm Regeneron Pharmaceuticals have started recruiting patients for tw...
Read More »
By Caroline Copley ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on produ...
Read More »By Susan Heavey WASHINGTON (Reuters) - Americans at high risk for heart problems who have been told for years to sharply cut salt fr...
Read More »
